Next Article in Journal
All-Round Manipulation of the Actin Cytoskeleton by HIV
Previous Article in Journal
Virus–Bacteria Interactions: Implications and Potential for the Applied and Agricultural Sciences
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

A Simple Mechanism Based on Amino Acid Substitutions is not a Critical Determinant of High Mortality of Japanese Encephalitis Virus Infection in Mice

1
Department of Virology, Institute of Tropical Medicine, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan
2
Leading Graduate School Program, Nagasaki University, Nagasaki 852-8523, Japan
3
Center for Control and Prevention of Infectious Diseases, Nagasaki University, Nagasaki 852-8523, Japan
*
Author to whom correspondence should be addressed.
Current Affiliation: Institute of Virology, Philipps University Marburg, 35037 Marburg, Germany.
Current Affiliation: Laboratory of Zoonotic Diseases, Division of Health and Environmental Science, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu 069-8501, Japan.
Viruses 2018, 10(2), 62; https://doi.org/10.3390/v10020062
Submission received: 22 December 2017 / Revised: 24 January 2018 / Accepted: 1 February 2018 / Published: 3 February 2018
(This article belongs to the Section Animal Viruses)

Abstract

:
For the development of effective treatment strategies for Japanese encephalitis (JE), it is important to identify the viral factors causing severe disease during JE virus (JEV) infection. In this study, we assessed whether amino acid substitutions are critical factors for higher mortality of JaTH160 compared with JaOArS982 in mice using the technique of infectious cDNA clones. We raised the possibility that two amino acids of C124 and NS3482 of JaTH160 may contribute to increased mortality in mice. However, simultaneous substitutions of these amino acids did not significantly increase the virulence of JaOArS982, suggesting that high mortality due to JaTH160 viral infection cannot be simply attributed to the specific amino acids. Multiple and complex, but not simple, mechanisms may induce the high mortality of JaTH160 infection in mice.

1. Introduction

Japanese encephalitis (JE) virus (JEV) causes approximately 30,000 to 50,000 cases and 10,000 to 15,000 deaths in Asian countries annually [1,2]. JEV belongs to the family Flaviviridae, genus Flavivirus [3,4], whose genomic RNA encodes three structural (C, prM, and E) and seven nonstructural (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) proteins [5]. The clinical symptoms of JE vary from mild to severe disease, including a non-specific febrile illness, meningitis, encephalitis and meningoencephalitis [6,7]. However, the mechanism of severe central nervous system (CNS) disease has not been fully elucidated.
To evaluate the disease pathogenesis in JEV infection, mice have been employed as a useful infection model [8,9,10]. Mouse models of JEV infection have suggested that several viral and host factors affect disease severity during JEV infection. We previously showed that subcutaneous infection with the JaTH160 strain of JEV causes significantly higher mortality and more pronounced virus propagation in the brains of mice compared with those of the JaOArS982 strain [9]. Thus, we have considered that genome-based comparisons between JaTH160 and JaOArS982 strains would provide useful information for identifying the viral factors responsible for the pathogenicity in JEV infection in vivo.
Previous studies have demonstrated that amino acid substitutions are major factors affecting the virulence in flavivirus infections. For example, it has been shown that amino acid substitutions in the E protein, such as E49, E123, E138, E176, E306, and E389/390 affect the virulence of flaviviruses in the CNS [11,12,13,14], and amino acids, such as C42,43, prM15,17, NS2A23, and NS5879–881,891, contribute to the flavivirus pathogenicity in mice [15,16,17,18]. We have also focused on the amino acid substitutions between JaTH160 and JaOArS982 strains to elucidate the pathogenicity in our previous studies.
JaTH160, but not JaOArS982, expresses the NS1’ protein and that NS1’ enhances JEV production in avian cells and embryonated chicken eggs [19]. Previous studies have shown that the NS1’ protein plays a role in the enhanced virulence of the JEV SA14 strain in mice [20]. Thus, we have predicted that NS1’ protein is a critical factor of the higher pathogenicity of JaTH160 compared with JaOArS982. However, our data suggested that NS1’ protein expression in the JaOArS982 strain reduces the mortality in mice, suggesting that the effect of NS1’ on pathogenicity in vivo may vary among virus strains [21].
We also identified a unique amino acid of NS2A113 phenylalanine that affects the efficient propagation of JaTH160 in neuroblastoma Neuro-2a cells, but not extraneural origin cells compared with the JaOArS982 strain [22]. Therefore, we predicted that this NS2A113 phenylalanine is responsible for the high pathogenicity of JaTH160. However, this amino acid did not affect viral loads in the brain nor survival curves in mice, suggesting that virus propagation in vitro may not reflect the level of virus neurovirulence in vivo [22].
There are 19 amino acid differences between JaTH160 and JaOArS982. Therefore, in the present study, we aimed to identify the amino acids affecting the virulence and to assess whether those amino acid substitutions are critical to determine the high mortality due to JaTH160 infection by a reductionist approach using the infectious cDNA clone techniques of JaTH160 and JaOArS982 strains.

2. Materials and Methods

2.1. Ethical Statement

The animal experiment protocols were approved by the Animal Care and Use Committee of Nagasaki University (approval number: 091130-2/0912080807 December 8 2009, 100723-1/1008050873 August 5 2010). The animal experiments were performed in accordance with the recommendations in the Fundamental Guidelines for Proper Conduct of Animal Experiment and Related Activities in Academic Research Institutions under the jurisdiction of the Ministry of Education, Culture, Sports, Science, and Technology.

2.2. Viruses and Cells

The full-length cDNA clones S982-IC and JaTH-IC were developed from the genome sequences of JaOArS982 and JaTH160 strains, respectively, as described previously [19]. Based on the S982-IC and JaTH-IC, recombinant JEV clones were constructed at the unique restriction enzyme sites, and the point mutations were introduced by site-directed mutagenesis as described previously [19]. The plasmids containing the full-length cDNA clones were linearized and transcribed into RNA using an SP6 transcription kit (mMESSAGE mMACHINE SP6 kit, Life Technologies, Carlsbad, CA, USA) [23]. The RNAs were introduced into baby hamster kidney (BHK) cells by electroporation. Infectious viruses were recovered from those cell culture fluids. Virus stocks were stored at −80 °C until they were used. Viral titers were determined by plaque-forming assays using BHK cells and were expressed as plaque forming unit (PFU)/mL [24]. BHK cells were maintained in Eagle’s Minimal Essential Medium (EMEM) containing 10% fetal calf serum (FCS) and antibiotics.

2.3. Mice

C57BL/6j (B6) mice were purchased from Japan SLC, Inc, or Japan CLEA, Inc. Five- to seven-week-old mice were subcutaneously inoculated with 104 PFU of JEV diluted in EMEM containing 2% FCS. Mock infected mice were inoculated with supernatant of cultured BHK cells. Mice were weighed daily, and survivals were recorded for 21 days.

2.4. Statistical Analyses

The log-rank (Mantel-Cox) test was used for statistical analysis to assess the significant differences of survival curves between each recombinant virus and S982-infectious clone (IC) virus. A p value of <0.05 was considered statistically significant.

3. Results

3.1. Separate Regions of Viral Genome Affect the High Mortality in Mice

Amino acid differences between JaOArS982 and JaTH160 are shown in Figure 1A. S982-IC and JaTH-IC viruses showed 47 and 100% mortality in mice, respectively (Figure 1B). To address the amino acids affecting the different levels of virulence between these viruses, we applied the reductionist approach, which introduces JaTH-IC viral genome regions into S982-IC, and assessed those recombinant viruses by whether mortality reached high rates, ideally 100%. We expected this approach to narrow down the regions of viral genome stepwise and finally determine the amino acids of JaTH160 responsible for the high mortality in mice.
We first constructed four recombinant viruses (S-J1, S-J2, S-J3 and S-J4) based on S982-IC by introducing four regions of JaTH-IC (Figure 1C). Mortalities of S-J1-, S-J2-, S-J3-, and S-J4-infected mice were 80, 40, 50, and 67%, respectively, and S-J1 virus infection was found to cause higher mortality than others (Figure 1C).
We next constructed recombinant viruses of J-S1, J-S2, J-S3, and J-S4 based on JaTH-IC by replacing the four regions of S982-IC (Figure 2A). Infections with J-S2 and J-S4 viruses caused 100 and 91% mortality in mice, respectively (Figure 2A). On the other hand, infections with J-S1 and J-S3 viruses resulted in 55 and 73% mortality in mice, respectively (Figure 2A).
From these results, we postulated that a combination of distinct regions of 5’UTR-NS1323 and NS336-NS5567 may contribute to the high mortality due to JaTH-IC virus infection. Thus, we examined the mortality due to S-J13 virus infection in mice, whose regions of 5’UTR-NS1323 and NS336-NS5567 were of JaTH-IC, and other regions were of S982-IC (Figure 2B). The mortality rate of S-J13 virus-infected mice was 80%, although the survival curve was not significantly different from that of S982-IC virus (Figure 2B).
Although it is controversial as to whether the virulence of S-J13 virus is significantly higher than that of S982-IC virus, we further attempted to focus narrowly on the site of 5’UTR-NS1323 and NS336-NS5567. Thus, we further constructed recombinant viruses by dividing the 5’UTR-NS1323 and NS336-NS5567 regions into three and two regions, respectively.
Recombinant viruses of S-J13a and S-J13b were constructed as containing NS336-NS4B110 and NS4B111-NS5567 of JaTH-IC based on S-J1, respectively (Figure 3A). Mortality of S-J13a virus-infected mice was 100%, whereas that of S-J13b infected mice was 20% (Figure 3A). On the other hand, following infections with recombinant viruses of S-J1a3, S-J1b3, and S-J1c3 containing 5’UTR-M152, M153-E303, or E304-NS1323 of JaTH-IC based on S-J3, respectively, mortalities were 80, 70, and 60%, respectively, and S-J1a3 infection showed a higher mortality (Figure 3B).
From these results, we further focused on the amino acids in the 5’UTR-M152 and NS336-NS4B110 regions, where viral genome sequences of JaTH160 may induce high mortality in mice.

3.2. Amino Acids C124 and NS3482 of JaTH160 May Affect the High Mortality in Mice

To focus on amino acid substitutions, we next constructed recombinant viruses based on S-J3 and S-J1 by inserting a point mutation that substituted the amino acids in each 5’UTR-M152 and NS336-NS4B110 region.
There are two amino acid differences in the 5’UTR-M152 region between S982-IC and JaTH-IC. We constructed S-JC1243a and S-JM1403a as containing a point mutation of the position C124 and M140 based on S-J3, respectively (Figure 4A). After infections with these viruses, mortalities of mice were 100 and 80%, respectively (Figure 4A).
On the other hand, there are six amino acid differences in the NS336-NS4B110 region between S982-IC and JaTH-IC (Figure 1A). Thus, we constructed recombinant viruses of S-J1aNS3323, S-J1aNS3337, S-J1aNS3482, S-J1aNS3562, S-J1aNS4A3, and S-J1aNS4B18, to contain each point mutation of the position NS3323, NS3337, NS3482, NS3562, NS4A3, and NS4B18 of JaTH160 based on S-J1a, respectively (Figure 4B). Following infections with these viruses, mortalities of infected mice were 20, 63, 90, 60, 70, and 40%, respectively (Figure 4B).
These results suggested that the amino acids C124 and NS3482 of JaTH-IC may contribute to the high mortality of JaTH-IC infection, and provide the possibility that a combination of amino acids of C124 and NS3482 of JaTH160 is crucial for the cause of high mortality in mice.

3.3. Simultaneous Substitutions of C124 and NS3482 are Not Enough to Cause High Mortality

We predicted that simultaneous substitutions of C124 and NS3482 amino acids into S982-IC can increase mortality in mice. Therefore, to determine whether amino acids C124 and NS3482 of JaTH160 are responsible for the high mortality in mice, we inserted point mutations as containing C124 and NS3482 of JaTH160 based on S982-IC (S-JC124NS3482) and examined the mortality in virus-infected mice (Figure 4C). However, this virus infection resulted in 20% mortality in mice (Figure 4C).
These results indicated that a combination of amino acids C124 and NS3482 of JaTH160 is not a critical factor of the higher mortality of JaTH160 compared with JaOArS982.

4. Discussion

In this study, to assess whether amino acid differences were crucial determinants for the different mortalities between JaTH160 and JaOArS982 infections in vivo, we attempted to specify the amino acids responsible for the high mortality in mice by substituting the amino acids of JaOArS982 to JaTH160. Based on the stepwise approach to narrow down the genome region responsible for the high mortality of JEV using recombinant viruses derived from infectious cDNA clones, we archived two amino acid candidates of C124 and NS3482 that likely contribute to the increased mortality in mice. However, simultaneous substitutions of these amino acids based on the S982-IC did not result in high mortality like JaTH-IC virus infection in mice. From these observations, we suggest that high mortality due to JaTH160 virus infection cannot be attributed to a simple mechanism derived from specific amino acids of JaTH160, and that multiple and complex mechanisms contribute to the high mortality of JaTH160 virus infection in mice. We propose that a more sophisticated approach is required to elucidate the viral factors that determine the high virulence of JaTH160 in mice.
S-JC1243a and S-J1aNS3482 viruses induced high mortality in mice. However, the mechanism of the pathogenicity may be different between S-JC1243a and S-J1aNS3482 viruses. In the case of the S-JC1243a virus, the combination of C124 and the other amino acids or nucleotide sequences in the region of NS336-NS4B110 may be important for its pathogenicity. Moreover, the other amino acids located at close regions or separated regions could influence the C124-mediated viral pathogenicity. This theory is also applicable for S-J1aNS3482 infection. It is predicted that such substitutions of amino acids and nucleotides may compensate for the function inducing the high mortality of each virus. However, it is likely to be too complex to determine such viral genome factors. A simple reductionist approach is unlikely to be the practical method of obtaining such data.
We previously showed that JaTH160-infected mice developed severe infections of the CNS [9]. On the other hand, JaOArS982-infected mice exhibited varying degrees of encephalitis and different prognoses. We therefore proposed that fatal outcomes are attributable both to immunopathological changes and massive CNS infection [9]. However, it remains unclear whether severe CNS infection of JaTH160 is a direct cause of high mortality in mice or a result of a severe disease course including a specific immune response. In addition, our previous studies of JEV infection have shown that the mortality is not simply determined by neuroinvasiveness, because viral infections in the brains of surviving mice, that did not show apparent clinical signs, were similar levels of viral loads to those of dying mice [9]. These observations raise the possibility that different pathogenicity between JaOArS982 and JaTH160 infections may primarily be attributed to the peripherally induced host responses. Thus, both virus replication itself and host immune response induced by the virus infection should be focused on determining the viral factors for the fatal infection.
We also previously showed the increase of tumor necrosis factor alpha (TNF-α), interferon gamma (IFN-γ), interleukin (IL)-2, and IL-10 in the brain, and the decrease of TNF-α in the spleen in JaTH160 infected-mice [9]. From these observations we suggest that the varied disease symptoms in JE cases are primarily attributed to the immune response in individuals, and secondary viral factors contribute to the induction of such immune responses. Thus, to elucidate the mechanism of severe disease course based on the viral factors is still a priority in the development of effective treatment strategies for JE.

Acknowledgments

This work was supported by JSPS KAKENHI Grant Numbers JP16H05174, JP25304045, JP17H04661, JP15K15126, JP25660229, and JP23658243, and from the Japan Society for the Promotion of Science, Health and Labor Sciences Research Grant on Emerging and Re-emerging Infectious Diseases from the Japanese Ministry of Health, Labor and Welfare, Research on International Cooperation in Medical Science (Japan-US Cooperative Program), Health and Labor Sciences Research Grants, the Cooperative Research Grant(s) of NEKKEN, 2014, and the Japan Initiative for Global Research Network on Infectious Diseases.

Author Contributions

Yuki Takamatsu, and Daisuke Hayasaka conceived and designed the experiments; Yuki Takamatsu, Leo Uchida., Muhareva Raekiansyah, and Daisuke Hayasaka performed the experiments; Yuki Takamatsu and Daisuke Hayasaka analyzed the data; Yuki Takamatsu, Mark Anthony Luz, Kouichi Morita and Daisuke Hayasaka wrote the paper.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Ghosh, D.; Basu, A. Japanese encephalitis—A pathological and clinical perspective. PLoS Negl. Trop. Dis. 2009, 3, e437. [Google Scholar] [CrossRef] [PubMed]
  2. Solomon, T. Flavivirus encephalitis. N. Engl. J. Med. 2004, 351, 370–378. [Google Scholar] [CrossRef] [PubMed]
  3. Westaway, E.G.; Brinton, M.A.; Gaidamovich, S.; Horzinek, M.C.; Igarashi, A.; Kaariainen, L.; Lvov, D.K.; Porterfield, J.S.; Russell, P.K.; Trent, D.W. Flaviviridae. Intervirology 1985, 24, 183–192. [Google Scholar] [CrossRef] [PubMed]
  4. Gubler, D.J.; Kuno, G.; Markoff, L. Field's Virology, 5th ed.; Wolters Kluwer Lippincott Williams and Wilkins: Philadelphia, PA, USA, 2007; pp. 1153–1252. [Google Scholar]
  5. Sumiyoshi, H.; Hoke, C.H.; Trent, D.W. Infectious Japanese encephalitis virus RNA can be synthesized from in vitro-ligated cDNA templates. J. Virol. 1992, 66, 5425–5431. [Google Scholar] [PubMed]
  6. Tsai, T.F. New initiatives for the control of Japanese encephalitis by vaccination: Minutes of a WHO/CVI meeting, Bangkok, Thailand, 13–15 October 1998. Vaccine 2000, 18 (Suppl. 2), 1–25. [Google Scholar] [CrossRef]
  7. Misra, U.K.; Kalita, J. Overview: Japanese encephalitis. Prog. Neurobiol. 2010, 91, 108–120. [Google Scholar] [CrossRef] [PubMed]
  8. Aoki, K.; Shimada, S.; Simantini, D.S.; Tun, M.M.; Buerano, C.C.; Morita, K.; Hayasaka, D. Type-I interferon response affects an inoculation dose-independent mortality in mice following Japanese encephalitis virus infection. Virol. J. 2014, 11, 105. [Google Scholar] [CrossRef] [PubMed]
  9. Hayasaka, D.; Shirai, K.; Aoki, K.; Nagata, N.; Simantini, D.S.; Kitaura, K.; Takamatsu, Y.; Gould, E.; Suzuki, R.; Morita, K. TNF-α acts as an immunoregulator in the mouse brain by reducing the incidence of severe disease following Japanese encephalitis virus infection. PLoS ONE 2013, 8, e71643. [Google Scholar] [CrossRef] [PubMed]
  10. Fujii, Y.; Kitaura, K.; Nakamichi, K.; Takasaki, T.; Suzuki, R.; Kurane, I. Accumulation of T-cells with selected T-cell receptors in the brains of Japanese encephalitis virus-infected mice. Jpn. J. Infect. Dis. 2008, 61, 40–48. [Google Scholar] [PubMed]
  11. Lee, E.; Hall, R.A.; Lobigs, M. Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and west nile viruses. J. Virol. 2004, 78, 8271–8280. [Google Scholar] [CrossRef] [PubMed]
  12. Ni, H.; Burns, N.J.; Chang, G.J.; Zhang, M.J.; Wills, M.R.; Trent, D.W.; Sanders, P.G.; Barrett, A.D. Comparison of nucleotide and deduced amino acid sequence of the 5′ non-coding region and structural protein genes of the wild-type Japanese encephalitis virus strain SA14 and its attenuated vaccine derivatives. J. Gen. Virol. 1994, 75 Pt 6, 1505–1510. [Google Scholar] [CrossRef] [PubMed]
  13. Tajima, S.; Nerome, R.; Nukui, Y.; Kato, F.; Takasaki, T.; Kurane, I. A single mutation in the Japanese encephalitis virus E protein (S123R) increases its growth rate in mouse neuroblastoma cells and its pathogenicity in mice. Virology 2010, 396, 298–304. [Google Scholar] [CrossRef] [PubMed]
  14. Ni, H.; Chang, G.J.; Xie, H.; Trent, D.W.; Barrett, A.D. Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14. J. Gen. Virol 1995, 76 Pt 2, 409–413. [Google Scholar] [CrossRef] [PubMed]
  15. Mori, Y.; Okabayashi, T.; Yamashita, T.; Zhao, Z.; Wakita, T.; Yasui, K.; Hasebe, F.; Tadano, M.; Konishi, E.; Moriishi, K.; et al. Nuclear localization of Japanese encephalitis virus core protein enhances viral replication. J. Virol. 2005, 79, 3448–3458. [Google Scholar] [CrossRef] [PubMed]
  16. Kim, J.M.; Yun, S.I.; Song, B.H.; Hahn, Y.S.; Lee, C.H.; Oh, H.W.; Lee, Y.M. A single N-linked glycosylation site in the Japanese encephalitis virus prm protein is critical for cell type-specific prm protein biogenesis, virus particle release, and pathogenicity in mice. J. Virol. 2008, 82, 7846–7862. [Google Scholar] [CrossRef] [PubMed]
  17. Melian, E.B.; Hinzman, E.; Nagasaki, T.; Firth, A.E.; Wills, N.M.; Nouwens, A.S.; Blitvich, B.J.; Leung, J.; Funk, A.; Atkins, J.F.; et al. NS1’ of flaviviruses in the Japanese encephalitis virus serogroup is a product of ribosomal frameshifting and plays a role in viral neuroinvasiveness. J. Virol. 2010, 84, 1641–1647. [Google Scholar] [CrossRef] [PubMed]
  18. Yoshii, K.; Sunden, Y.; Yokozawa, K.; Igarashi, M.; Kariwa, H.; Holbrook, M.R.; Takashima, I. A critical determinant of neurological disease associated with highly pathogenic tick-borne flavivirus in mice. J. Virol. 2014, 88, 5406–5420. [Google Scholar] [CrossRef] [PubMed]
  19. Takamatsu, Y.; Okamoto, K.; Dinh, D.T.; Yu, F.; Hayasaka, D.; Uchida, L.; Nabeshima, T.; Buerano, C.C.; Morita, K. NS1’ protein expression facilitates production of Japanese encephalitis virus in avian cells and embryonated chicken eggs. J. Gen. Virol. 2014, 95, 373–383. [Google Scholar] [CrossRef] [PubMed]
  20. Ye, Q.; Li, X.F.; Zhao, H.; Li, S.H.; Deng, Y.Q.; Cao, R.Y.; Song, K.Y.; Wang, H.J.; Hua, R.H.; Yu, Y.X.; et al. A single nucleotide mutation in NS2A of Japanese encephalitis-live vaccine virus (SA14-14-2) ablates NS1’ formation and contributes to attenuation. J. Gen. Virol. 2012, 93, 1959–1964. [Google Scholar] [CrossRef] [PubMed]
  21. Takamatsu, Y.; Raekiansyah, M.; Morita, K.; Hayasaka, D. NS1’ protein expression in the JaOArS982 strain of Japanese encephalitis virus does not enhance virulence in mice. Trop. Med. Health 2015, 43, 233–237. [Google Scholar] [CrossRef] [PubMed]
  22. Takamatsu, Y.; Morita, K.; Hayasaka, D. A single amino acid substitution in the NS2A protein of Japanese encephalitis virus affects virus propagation in vitro but not in vivo. J. Virol. 2015, 89, 6126–6130. [Google Scholar] [CrossRef] [PubMed]
  23. Hayasaka, D.; Gritsun, T.S.; Yoshii, K.; Ueki, T.; Goto, A.; Mizutani, T.; Kariwa, H.; Iwasaki, T.; Gould, E.A.; Takashima, I. Amino acid changes responsible for attenuation of virus neurovirulence in an infectious cDNA clone of the oshima strain of tick-borne encephalitis virus. J. Gen. Virol. 2004, 85, 1007–1018. [Google Scholar] [CrossRef] [PubMed]
  24. Hayasaka, D.; Nagata, N.; Fujii, Y.; Hasegawa, H.; Sata, T.; Suzuki, R.; Gould, E.A.; Takashima, I.; Koike, S. Mortality following peripheral infection with tick-borne encephalitis virus results from a combination of central nervous system pathology, systemic inflammatory and stress responses. Virology 2009, 390, 139–150. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Mortalities of mice infected with recombinant viruses of JaOArS982 and JaTH160 replacing four distinct regions of the viral genome. (A) schematic representation of 19 amino acid differences of recombinant S982-IC and JaTH-IC viruses derived from JaOArS982 and JaTH160, respectively. Numbers indicate the position of amino acid in each responsible protein, respectively. (B) Survival curves and mortality rates of mice infected with 104 pfu of S982-IC (n = 15) and JaTH-IC (n = 15) for 21 days. Opened and closed diamonds indicate S982-IC and JaTH-IC, respectively. The log-rank (Mantel-Cox) test was used for statistical analysis to assess significant differences of survival curves. A p value of <0.05 was considered statistically significant. (C) Survival curves and mortality rates of mice infected with 104 pfu of S-J1 (n = 10), S-J2 (n = 10), S-J3 (n = 9) and S-J4 (n = 9) viruses based on S982-IC, in which genome regions 1 (5’ untranslated region (UTR)-NS1323), 2 (NS1324-NS335), 3 (NS336-NS5567), and 4 (NS5567-3’UTR) were replaced with those of S982-IC, respectively. Closed triangles indicate recombinant viruses. The black inverted triangles indicate the positions and numbers of amino acids derived from JaTH-IC.
Figure 1. Mortalities of mice infected with recombinant viruses of JaOArS982 and JaTH160 replacing four distinct regions of the viral genome. (A) schematic representation of 19 amino acid differences of recombinant S982-IC and JaTH-IC viruses derived from JaOArS982 and JaTH160, respectively. Numbers indicate the position of amino acid in each responsible protein, respectively. (B) Survival curves and mortality rates of mice infected with 104 pfu of S982-IC (n = 15) and JaTH-IC (n = 15) for 21 days. Opened and closed diamonds indicate S982-IC and JaTH-IC, respectively. The log-rank (Mantel-Cox) test was used for statistical analysis to assess significant differences of survival curves. A p value of <0.05 was considered statistically significant. (C) Survival curves and mortality rates of mice infected with 104 pfu of S-J1 (n = 10), S-J2 (n = 10), S-J3 (n = 9) and S-J4 (n = 9) viruses based on S982-IC, in which genome regions 1 (5’ untranslated region (UTR)-NS1323), 2 (NS1324-NS335), 3 (NS336-NS5567), and 4 (NS5567-3’UTR) were replaced with those of S982-IC, respectively. Closed triangles indicate recombinant viruses. The black inverted triangles indicate the positions and numbers of amino acids derived from JaTH-IC.
Viruses 10 00062 g001
Figure 2. Mortalities of mice infected with recombinant viruses based on S982-IC and JaTH-IC. (A) Survival curves and mortality rates of mice infected with 104 pfu of J-S1 (n = 11), J-S2 (n = 13), J-S3 (n = 11), and J-S4 (n = 11) viruses based on JaTH-IC, in which genome regions 1, 2, 3, and 4 were replaced with those of S982-IC, respectively. (B) Survival curves and mortality rates of mice infected with 104 pfu of S-J13 (n = 10) and S-J24 (n = 10), whose genome regions 1 and 3, or regions 2 and 4, were of JaTH-IC. Closed triangles indicate recombinant viruses. The black inverted triangles indicate the positions and numbers of amino acids derived from JaTH-IC.
Figure 2. Mortalities of mice infected with recombinant viruses based on S982-IC and JaTH-IC. (A) Survival curves and mortality rates of mice infected with 104 pfu of J-S1 (n = 11), J-S2 (n = 13), J-S3 (n = 11), and J-S4 (n = 11) viruses based on JaTH-IC, in which genome regions 1, 2, 3, and 4 were replaced with those of S982-IC, respectively. (B) Survival curves and mortality rates of mice infected with 104 pfu of S-J13 (n = 10) and S-J24 (n = 10), whose genome regions 1 and 3, or regions 2 and 4, were of JaTH-IC. Closed triangles indicate recombinant viruses. The black inverted triangles indicate the positions and numbers of amino acids derived from JaTH-IC.
Viruses 10 00062 g002
Figure 3. Mortalities of mice infected with S-J13-based recombinant viruses. (A) Survival curves and mortality rates of mice infected with 104 pfu of S-J13a (n = 10) and S-J13b (n = 5) based on S-J13, in which regions 3a (NS336-NS4B110) and 3b (NS4B111-NS5567) were replaced with those of JaTH-IC. (B) Survival curves and mortality rates of mice infected with 104 pfu of S-J1a3 (n = 10), S-J1b3 (n = 10), and S-J1c3 (n = 5) based on S-J13, in which regions 1a (5’UTR-M152), 1b (M153-E303), and 1c (E304-NS1323) were replaced with those of JaTH-IC. Closed triangles indicate recombinant viruses. The black inverted triangles indicate the positions and numbers of amino acids derived from JaTH-IC.
Figure 3. Mortalities of mice infected with S-J13-based recombinant viruses. (A) Survival curves and mortality rates of mice infected with 104 pfu of S-J13a (n = 10) and S-J13b (n = 5) based on S-J13, in which regions 3a (NS336-NS4B110) and 3b (NS4B111-NS5567) were replaced with those of JaTH-IC. (B) Survival curves and mortality rates of mice infected with 104 pfu of S-J1a3 (n = 10), S-J1b3 (n = 10), and S-J1c3 (n = 5) based on S-J13, in which regions 1a (5’UTR-M152), 1b (M153-E303), and 1c (E304-NS1323) were replaced with those of JaTH-IC. Closed triangles indicate recombinant viruses. The black inverted triangles indicate the positions and numbers of amino acids derived from JaTH-IC.
Viruses 10 00062 g003
Figure 4. Mortalities of mice infected with recombinant viruses inserting point mutations. (A) Survival curves and mortality rates of mice infected with 104 pfu of S-JC1243a (n = 10) and S-JM1403a (n = 10) viruses based on S982-IC containing genome region 3a of JaTH-IC, in which amino acids C124 and M140 were replaced with those of JaTH-IC, respectively. (B) Survival curves and mortality rates of mice infected with 104 pfu of S-J1aNS3323 (n = 5), S-J1aNS3337 (n = 8), S-J1aNS3482 (n = 10), S-J1aNS3562 (n = 5), S-J1aNS4A3 (n = 10), and S-J1aNS4B18 (n = 5) viruses based on S982-IC containing genome region 1a of JaTH-IC, in which amino acids NS3323, NS3337, NS3482, NS3562, NS4A3, and NS4B18 were replaced with those of JaTH-IC, respectively. (C) Survival curves and mortality rates of mice infected with 104 pfu of S-J C124NS3482 (n = 10) virus based on S982-IC, whose amino acid positions of C124 and NS3482 were of JaTH160-IC. Closed triangles indicate recombinant viruses. The black inverted triangles indicate the positions and numbers of amino acids derived from JaTH-IC.
Figure 4. Mortalities of mice infected with recombinant viruses inserting point mutations. (A) Survival curves and mortality rates of mice infected with 104 pfu of S-JC1243a (n = 10) and S-JM1403a (n = 10) viruses based on S982-IC containing genome region 3a of JaTH-IC, in which amino acids C124 and M140 were replaced with those of JaTH-IC, respectively. (B) Survival curves and mortality rates of mice infected with 104 pfu of S-J1aNS3323 (n = 5), S-J1aNS3337 (n = 8), S-J1aNS3482 (n = 10), S-J1aNS3562 (n = 5), S-J1aNS4A3 (n = 10), and S-J1aNS4B18 (n = 5) viruses based on S982-IC containing genome region 1a of JaTH-IC, in which amino acids NS3323, NS3337, NS3482, NS3562, NS4A3, and NS4B18 were replaced with those of JaTH-IC, respectively. (C) Survival curves and mortality rates of mice infected with 104 pfu of S-J C124NS3482 (n = 10) virus based on S982-IC, whose amino acid positions of C124 and NS3482 were of JaTH160-IC. Closed triangles indicate recombinant viruses. The black inverted triangles indicate the positions and numbers of amino acids derived from JaTH-IC.
Viruses 10 00062 g004aViruses 10 00062 g004b

Share and Cite

MDPI and ACS Style

Takamatsu, Y.; Uchida, L.; Raekiansyah, M.; Luz, M.A.; Morita, K.; Hayasaka, D. A Simple Mechanism Based on Amino Acid Substitutions is not a Critical Determinant of High Mortality of Japanese Encephalitis Virus Infection in Mice. Viruses 2018, 10, 62. https://doi.org/10.3390/v10020062

AMA Style

Takamatsu Y, Uchida L, Raekiansyah M, Luz MA, Morita K, Hayasaka D. A Simple Mechanism Based on Amino Acid Substitutions is not a Critical Determinant of High Mortality of Japanese Encephalitis Virus Infection in Mice. Viruses. 2018; 10(2):62. https://doi.org/10.3390/v10020062

Chicago/Turabian Style

Takamatsu, Yuki, Leo Uchida, Muhareva Raekiansyah, Mark Anthony Luz, Kouichi Morita, and Daisuke Hayasaka. 2018. "A Simple Mechanism Based on Amino Acid Substitutions is not a Critical Determinant of High Mortality of Japanese Encephalitis Virus Infection in Mice" Viruses 10, no. 2: 62. https://doi.org/10.3390/v10020062

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop